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INTRODUCTION 1
Older age is a primary risk factor for the development of cardiovascular diseases [1, 2] . 2
The influence of advanced age on increased cardiovascular risk is, at least partly, 3 mediated through its effects on the arterial vasculature [1] . In this regard, ageing is 4 associated with vascular endothelial dysfunction in humans, characterized by reduced 5 endothelium-dependent vasodilator function in conduit [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and resistance [6, 9, 24] arteries. Alterations in the nitric oxide (NO) signaling pathway and/or decreased 7 NO bioavailability have been proposed to contribute to the age-related decrease in 8 endothelium-dependent vasodilator function [25, 26] . 9 
10
The ability of vessels to dilate is dependent on the function of the endothelium, but is 11 also subordinated to vascular smooth muscle (vasodilator) function (SMF). Smooth 12 muscle responsiveness represents the final, and frequently underappreciated, step of 13 endothelium-dependent vasodilation. However, relatively little is known about the 14 impact of advanced age on SMF. Some reports from animal studies indicate that 15 advanced age is associated with reduced vascular SMF [27] [28] [29] ; nonetheless, this finding 16 is not universal [25] . In humans, studies assessing vascular SMF in healthy older and 17 young subjects have reported variable results, possibly as a result of small sample sizes 18 [3-6, 8-10, 12, 14-24, 30-43] . 19 20 Therefore, the primary aim of this study was to perform a systematic review and meta-21 analyses of available studies comparing vascular SMF in older and young healthy 22 subjects. We hypothesized that SMF would be reduced in conduit and resistance 23 arteries of older compared with young healthy adults. We selected studies that 24 assessed SMF, determined by the endothelium-independent vasodilator response to 25 exogenous NO donors, in the brachial artery (BASMF) and in resistance arteries 26 (RASMF) of healthy young and healthy older subjects. 27
28

METHODS 29
The review is reported according to the Meta-analysis Of Observational Studies in 30 Epidemiology (MOOSE) Group guidelines [44] . 31 32
Data sources and searches 33
Our systematic search included MEDLINE, Cochrane and Scopus, since their 34 inceptions until January 2014. We used combinations of the subject headings "older", 35 "vascular smooth muscle", "endothelium independent", "nitroglycerin", "sodium 36 nitroprusside", "vascular function", "vasodilation" and "vascular reactivity"; the search 37 strategy for MEDLINE is shown in Supplemental Figure S 1 . We also performed hand 38 searching in reference citations of articles included in meta-analysis and related 39 citations in MEDLINE. 40 
41
Study selection 42
To be included in the analysis, an observational report had to assess BASMF and/or 43 RASMF in an older group (mean age ≥60 years) and a young group (mean age <30 44 years) of healthy subjects. In the event of multiple publications pertaining to the same 45 research, the first published or most comprehensive study was included. Inclusion of 46 studies was not limited by publication status or language. 47
The following variables were extracted into a pre-formatted spreadsheet: authors, year 50 of publication, characteristics of study participants (n, gender, age, height, weight, body 51 mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), 52 physical activity, maximal oxygen consumption (VO 2max ), morbidities, risk factors to 53 health, medication) and vascular variables (vascular region, vasodilation parameter, 54 baseline vascular tone, NO donor, dosage, time of analysis after NO donor 55 administration, wall-tracking system, BASMF, RASMF, endothelial function). A 56 systematic appraisal of quality for observational research (SAQOR) [45] previously 57 applied in meta-analysis of observational studies evaluating arterial function [46] was 58 performed to provide assessment of study quality. The SAQOR was adjusted to assess 59 1) the older sample group, 2) the young sample group, 3) quality of vascular SMF 60 measurement, 4) confounding variables and 5) data. Overall, the SAQOR was scored 61 out of 16, quality deemed better with a greater score (Table S 1 and S 2 ) . 62
63
Data synthesis and analysis 64
The meta-analyses and subgroup analyses were performed using Review Manager 65 software (RevMan 5.2, Cochrane Collaboration, Oxford, UK). The primary outcomes 66 were the mean difference (MD) in BASMF and the standardized mean difference (SMD) 67 in RASMF between older and young groups. SMD summary statistic allowed us to 68 standardize RASMF values expressed in different units into a uniform scale to complete 69 this meta-analysis. Each MD and SMD was weighted according to the inverse variance 70 method [47] and they were pooled with a random-effects model [48] . SMD of 0.2, 0.5, 71 and 0.8 represents small, medium, and large effect sizes, respectively [49] . 72
Heterogeneity between studies was assessed using the chi-squared test for 73 [50] . A P value of less than 0.05 78 was considered statistically significant. 79
80
RESULTS
81
Study selection and characteristics 82
The flow diagram of the process of study selection is shown in Figure 1 , which resulted 83 in the inclusion of 33 articles. Thirteen of these articles assessed BASMF, 19 assessed 84 RASMF and 1 assessed both BASMF and RASMF. One of the articles assessing BASMF 85 presented two groups of older subjects, each of which had been independently 86 compared with a location-matched young group [43] . Therefore, these data were 87 evaluated as two individual studies. The quality of the studies was moderate-to-high according to a previously validated 95 scale [45, 51] . The mean score was 13.9±1.2 for studies assessing BASMF and 11.8±1.2 96 for studies assessing RVSMF, out of a possible 16 points (Table S 1 (Table S 3 ). In addition, lower brachial artery endothelial function in older 115 compared with young groups was related to lower BASMF (P=0.03, Table S 3 ) . No 116 other potential moderating factor (n, age, height, weight, BMI, SBP, DBP, VO 2max , 117 vascular assessment, methodological quality, year of publication) significantly influenced 118 the MD in BASMF between older and young groups in subgroup analyses (Table S 3 ) . 119 120
Resistance artery smooth muscle function (RASMF) 121
RASMF was determined by evaluating the absolute peak [6, 14, 15, 18, 23, 24, [30] [31] [32] [33] 122 35], percent increase from baseline [8, 9, 16, 17, [19] [20] [21] , 34] or slope [22] in 123 vasodilation in response to sodium nitroprusside (Table 3) . After data pooling, the 124 In this systematic review and meta-analysis, we pooled and analyzed data from 33 137 articles comparing vascular SMF, determined by the vasodilator response to exogenous 138 NO donors, in 550 older and 516 young healthy subjects. The main finding of this 139 meta-analysis is that vascular SMF is significantly lower in older compared to young 140 individuals, a finding that is similarly present in conduit and resistance arteries ( Figure 2  141 and 3). In subgroup analyses, we found that sex altered the impact of age on vascular 142 SMF. More specifically, studies including females only or a higher ratio of females to 143 males displayed a significant and marked impact of age on conduit and resistance artery 144 SMF, whilst studies involving males only or a lower ratio of females to males reported 145 no effect of age on SMF (Table S 3 ) . 146
147
The impact of age on vascular SMF had not been explored in detail in most previous 148 individual studies (Table 2 and mediates vasodilation via formation of cyclic guanosine monophosphate (cGMP) [53] ). 157
In humans, decreased expression and activity of sGC in brain tissue have been related 158 to advanced age and Alzheimer's disease, respectively, although no specific vascular 159 measures were provided [54, 55] . Whether an age-related reduction in expression and 160 activity of sGC in vascular smooth muscle contributes to a blunted vascular 161 responsiveness to NO needs further investigation. 162 163 A consistent finding from previous studies is that brachial artery flow-mediated 164 dilation, as well as resistance artery responses to acetylcholine, are impaired in older 165 healthy humans. As most of these previous studies found no difference in the 166 endothelium-independent vasodilation to exogenous NO donors, the general 167 consensus was that the lower flow-mediated dilation and resistance artery responses 168 to acetylcholine supported the presence of a dysfunctional endothelium. Our results, 169 however, suggest the presence of a small-to-moderate but significant age-related 170 impairment in SMF that is present across the vascular tree. Moreover, our finding also 171
suggests that a portion of the impaired NO-dependent responses in conduit and 172 resistance arteries in older healthy subjects may be in part due to reduced smooth 173 muscle sensitivity to NO. This important observation should be taken into 174 consideration when interpreting the lower NO-dependent responses in healthy older 175
humans. 176
Another
NO donors has been reported in conduit and resistance arteries of healthy older 186 women but not in those on hormonal replacement therapy. This suggests that 187 hormone replacement therapy in postmenopausal women may preserve the sensitivity 188 of vascular smooth muscle to NO [56] [57] [58] . In this regard, it is important to emphasize 189 that none of the studies included in our meta-analyses involved women on hormonal 190 therapy. Consequently, based on the assumption that the majority of older women 191 were post-menopausal, the lower vascular SMF in older groups could be a result of the 192 loss of vascular protection from circulating estrogens associated with post-menopause. 193
Nevertheless, removal of estrogen with ovariectomy in rodents does not appear to 194
alter vasodilator responses to sodium nitroprusside [59, 60] , suggesting that loss of 195 estrogen after menopause may not be the sole factor contributing to reduced vascular 196 SMF in older women. Alternatively, estrogen-independent alterations in the NO 197 signaling pathway could underlie the altered vascular SMF in older women in view of 198 the decreased NO-stimulated vascular cGMP formation in middle-aged and older 199 women (with no report of menopause) compared with men [61] . Whilst speculative, 200 the sex-related reduced vascular sensitivity to NO might partly explain why women 201 remain more symptomatic and present lower cardiovascular status compared with 202 men after long-term nitrate therapy for heart failure [62] . 203
204
A potential explanation for a lower NO-mediated dilation of the brachial artery in 205 older subjects may relate to the larger baseline diameter. As demonstrated in several 206 previous studies, the brachial artery dilator response to ischemia or glyceryl trinitrate 207 is inversely related to the baseline diameter [63] [64] [65] [66] [67] . Nonetheless, in the present study, 208 the difference in baseline brachial diameter between older and young groups did not 209 modify the MD in BASMF according to subgroup analysis (Table S 3 ). Moreover, the 210 magnitude of the difference in baseline brachial diameter between older men and 211 young men (4 studies) was not different than the difference between older women and 212 young women (3 studies) (P=0.24). Furthermore, the impact of sex on BASMF is not 213 explained by artery diameter [68] . Taken together, we believe differences in brachial 214 artery diameter between older and young groups do not entirely explain the age-215 related decline in BASMF observed in the present meta-analysis. 216
217
As for the prognostic value of vascular SMF, adverse cardiovascular events were 218 associated with reduced smooth muscle sensitivity to NO in high-risk populations 219 when assessed in conduit [69] and resistance arteries [70] by means of ultrasound and 220 plethysmography, respectively. It should be noted that blood flow responses in the 221 microcirculation assessed via plethysmography and laser Doppler techniques -such as 222 those used in the studies included in the RASMF meta-analysis-may be, to a certain 223 degree, dependent on microvascular structure, which in turn is strongly associated 224 with cardiovascular events [71] . Conversely, NO-dependent responses determined by 225 micromyography did not predict cardiovascular events in high-risk patients, suggesting 226 that resistance artery function per se has low clinical relevance [72] . Similarly, it cannot 227 be discarded that the age-related reduction in RASMF is an observation dependent on 228 differences in microvascular structure. Further research is warranted to determine the 229 extent to which vascular structural changes with ageing influence the non-invasive 230 estimates of smooth muscle responsiveness to NO and their clinical significance. 231
232
There are some limitations in this meta-analysis. First, cross-sectional comparisons may 233 be misleading when addressing the question of the impact of advanced age [73] . 234
Second, we were unable to accurately determine the level of physical activity or fitness 235 in the included studies. Since physical activity or exercise training has well-established 236 effects on endothelial function [74] , we were unable to identify the potential impact of 237 this factor on our results. Likewise, body composition, fat distribution and blood lipids 238 could be suggested as potential moderating factors, albeit not investigated in this meta-239 analysis. Third, although single-dose (0.4 mg of nitroglycerin) is the common procedure 240 to evaluate BASMF (Table 2) , there are physiological and methodological variables that 241 may affect the reproducibility of BASMF [75, 76] . In addition, the administration of 0.4 242 mg of nitroglycerin is considered to induce a maximal NO-mediated vasodilator 243 response [75] , which could be dissociated from vascular smooth muscle submaximal 244 responses to lower or step-wise doses of NO. In this respect, dose-response studies 245 might have higher sensitivity to detect small differences in BASMF between older and 246 young groups [75] . 247
In conclusion, the current meta-analysis provides evidence that advanced age is 249 associated with a relatively small, but significant impairment in conduit and resistance 250 artery SMF in healthy humans. The magnitude of vascular smooth muscle dysfunction 251 seems more prevalent in women than in men, potentially related to the loss of 252 circulating estrogens in women after menopause. A potential implication of our finding 253 is that the impairment in conduit and resistance artery endothelial function with 254 advanced age may, at least in part, be attributed to changes in vascular SMF in healthy 255 adults. Further studies are needed to determine sex-related mechanisms that may 256 influence the ageing-associated alterations in vascular SMF in humans. 
